Combining Multi-kinase Inhibitors and Immune Checkpoints Blockade in Hepatocellular Carcinoma: A Pharmacotherapeutic Approach
Liver cancer, particularly hepatocellular carcinoma (HCC), represents a significant global health burden with limited treatment options and poor prognosis. This article provides a comprehensive overview of pharmacotherapy for liver cancer, focusing on both established and emerging drugs. Curren...
Saved in:
Main Authors: | Vothani Sarath Babu, P Bhavana Sree, C Pallavi, S Pavithra, P M Vasanth |
---|---|
Format: | Article |
Language: | English |
Published: |
Krupanidhi College of Pharmacy
2024-11-01
|
Series: | Journal of Pharmaceutical Research |
Online Access: | https://jopcr.com/articles/combining-multi-kinase-inhibitors-and-immune-checkpoints-blockade-in-hepatocellular-carcinoma-a-pharmacotherapeutic-approach |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma
by: Brandon M. Meyers, et al.
Published: (2025-07-01) -
Liver function dynamics in advanced hepatocellular carcinoma receiving immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization
by: Chen-You Liu, et al.
Published: (2025-06-01) -
CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015-10-01) -
Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
by: Jürgen Braun, et al.
Published: (2024-11-01) -
Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
by: K. V. Menshikov, et al.
Published: (2022-10-01)